dosedrugsOnlineOfflineع
You're offline — running on data saved to your device.

Gefitinib: prices and alternatives

Gefitinib is an EGFR tyrosine kinase inhibitor indicated as first-line treatment of adults with metastatic non-small cell lung cancer (NSCLC) whose tumors harbor EGFR exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test.

2 products with this active ingredient from 2 manufacturers. Official prices from 6209 to 14624 EGP.

Every box with this active ingredient, cheapest first.

Gefitinib hexal 250mg 30 f.c.tabsGefitinib hexal 250mg 30 f.c.tabsجيفيتينيب هيكسال 250مجم 30 قرصgefitinib · Novartis Pharma Sandoz DivisionOfficial public price6209EGP
Iressa 250mg 30 tabsIressa 250mg 30 tabsاريسا 250مجم 30 قرصgefitinib · Astra ZenecaOfficial public price14624EGP

Informational only — may be inaccurate or incomplete. Don't rely on it medically; verify with a pharmacist.